Advanced search
Publication Cover
Modern Rheumatology Volume 22, 2012 - Issue 1
Journal homepage
25
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Efficacy of low-dose imatinib mesylate for cutaneous involvement in systemic sclerosis: a preliminary report of three cases

Zenshiro TamakiDepartment of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan
,
Yoshihide AsanoDepartment of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, JapanCorrespondence[email protected]
,
Masaru HatanoDepartment of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan
,
Atsushi YaoDepartment of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan
,
Tomohiko KawashimaDepartment of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan
,
Manabu TomitaDepartment of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan
,
Koichiro KinugawaDepartment of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan
,
Ryozo NagaiDepartment of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan
&
Shinichi SatoDepartment of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan
 show all
Pages 94-99 | Received 21 Feb 2011, Accepted 10 May 2011, Published online: 02 Jan 2014

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Vasiliki Liakouli, Jacopo Ciaffi, Francesco Ursini, Piero Ruscitti, Riccardo Meliconi, Francesco Ciccia, Paola Cipriani & Roberto Giacomelli. (2020) Efficacy and safety of imatinib mesylate in systemic sclerosis. A systematic review and meta-analysis. Expert Review of Clinical Immunology 16:9, pages 931-942.
Read now
Pia Moinzadeh, Nicolas Hunzelmann & Thomas Krieg. (2013) Pharmacology and rationale for imatinib in the treatment of scleroderma. Journal of Experimental Pharmacology 5, pages 15-22.
Read now

Articles from other publishers (9)

Fabian A. Mendoza, Sonsoles Piera-Velazquez & Sergio A. Jimenez. (2021) Tyrosine kinases in the pathogenesis of tissue fibrosis in systemic sclerosis and potential therapeutic role of their inhibition. Translational Research 231, pages 139-158.
Crossref
Yoshihide Asano, Masatoshi Jinnin, Yasushi Kawaguchi, Masataka Kuwana, Daisuke Goto, Shinichi Sato, Kazuhiko Takehara, Masaru Hatano, Manabu Fujimoto, Naoki Mugii & Hironobu Ihn. (2018) Diagnostic criteria, severity classification and guidelines of systemic sclerosis. The Journal of Dermatology 45:6, pages 633-691.
Crossref
Charles Khouri, Sophie Blaise, Patrick Carpentier, Céline Villier, Jean-Luc Cracowski & Matthieu Roustit. (2016) Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers. British Journal of Clinical Pharmacology 82:1, pages 6-16.
Crossref
Manabu Fujimoto & Kazuhiko Takehara. 2016. Systemic Sclerosis. Systemic Sclerosis 137 153 .
Vasco Coelho-Macias, Pedro Mendes-Bastos, Fernando Assis-Pacheco & Jorge Cardoso. (2014) Imatinib: a novel treatment approach for generalized morphea. International Journal of Dermatology 53:10, pages 1299-1302.
Crossref
Matthieu Roustit, Charles Khouri, Sophie Blaise, Céline Villier, Patrick Carpentier & Jean-Luc Cracowski. (2014) Pharmacologie du phénomène de Raynaud. Therapies 69:2, pages 115-128.
Crossref
Yoshihide ASANO. (2014) A unifying hypothesis for the pathogenesis of systemic sclerosis based on the deficiency of transcription factor Fli1 – the development of a new animal model of systemic sclerosis –. Japanese Journal of Clinical Immunology 37:6, pages 475-487.
Crossref
Kaname Akamata, Yoshihide Asano, Naohiko Aozasa, Shinji Noda, Takashi Taniguchi, Takehiro Takahashi, Yohei Ichimura, Tetsuo Toyama & Shinichi Sato. (2014) Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1. Arthritis Research & Therapy 16:2, pages R86.
Crossref
Atsushi Yao. (2012) Recent advances and future perspectives in therapeutic strategies for pulmonary arterial hypertension. Journal of Cardiology 60:5, pages 344-349.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.